JPH11512108A - 鎮痛薬としての光学活性フェニルピリミジン誘導体 - Google Patents
鎮痛薬としての光学活性フェニルピリミジン誘導体Info
- Publication number
- JPH11512108A JPH11512108A JP9510854A JP51085497A JPH11512108A JP H11512108 A JPH11512108 A JP H11512108A JP 9510854 A JP9510854 A JP 9510854A JP 51085497 A JP51085497 A JP 51085497A JP H11512108 A JPH11512108 A JP H11512108A
- Authority
- JP
- Japan
- Prior art keywords
- salt
- dichlorophenyl
- diamino
- acid addition
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 式(I)のピリミジンまたはその酸付加塩。 2. 薬学的に許容される酸付加塩である、請求項1に記載の塩。 3. スルフェート、ホスフェートまたはイセチオネート塩である、請求項1 に記載の塩。 4. ヒドロクロリドまたはメタンスルホネート塩である、請求項1に記載の 塩。 5. 請求項1に記載の式(I)のピリミジンまたはその酸付加塩の製造法で あって、 (i) ラセミ2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6−フル オロメチルピリミジンを適当なキラル酸で分割し、得られた塩を再結晶してR( −)−2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6−フルオロメ チルピリミジンとの塩のみから実質的になる塩を得ること;並びに (ii) 所望ならば、再結晶塩を遊離塩基または必要に応じて別の酸付加塩に変 換すること を含む方法。 6. 請求項1に記載の式(I)のピリミジンまたはその酸付加塩の製造法で あって、 (a) ラセミ2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6−ヒ ドロキシメチルピリミジンを適当なキラル酸で分割し、得られた塩を再結晶して (−)−2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6−ヒドロキ シメチルピリミジンとの塩のみから実質的になる塩を得ること; (b) 所望ならば、再結晶塩を遊離塩基または別の塩に変換すること; (c) 工程(a)からの再結晶塩または工程(b)からの遊離塩基もしくは他 の塩を、(−)−2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6− ヒドロキシメチルピリミジンまたは得られた(−)−2,4−ジアミノ−5−( 2,3−ジクロロフェニル)−6−フルオロメチルピリミジンのラセミ化が生じ ない条件下でフッ素化すること;並びに (d) 所望ならば、得られたフッ素化化合物を遊離塩基にまたは必要に応じて その酸付加塩に変換すること を含む方法。 7. 活性成分として、請求項1に記載の式(I)のピリミジンまたはその薬 学的に許容される酸付加塩、および薬学的に許容される担体または希釈剤を含む 、医薬配合物。 8. 治療に使用するための、請求項1に記載の式(I)のピリミジンまたは その薬学的に許容される酸付加塩。 9. 鎮痛薬もしくは抗てんかん薬、または過敏性腸症候群もしくは二極性疾 患の治療用薬剤の製造に使用するための、請求項1に記載の式(I)のピリミジ ンまたはその薬学的に許容される酸付加塩。 10. 鎮痛薬もしくは抗てんかん薬、または機能性腸疾患、二極性疾患もし くは神経変性疾患の治療用薬剤、または依存症誘導薬剤における依存の予防もし くは軽減のための薬剤、または依存症誘導薬剤への耐性を予防もしくは軽減する ための薬剤の製造に使用するための、請求項1に記載の式(I)のピリミジンま たはその薬学的に許容される酸付加塩。 11. 式(III)のピリミジン。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9518027.9A GB9518027D0 (en) | 1995-09-05 | 1995-09-05 | Pharmacologically active compound |
GB9518027.9 | 1995-09-05 | ||
PCT/EP1996/003856 WO1997009317A2 (en) | 1995-09-05 | 1996-09-03 | Optically active phenyl pyrimidine derivative as analgesic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11512108A true JPH11512108A (ja) | 1999-10-19 |
Family
ID=10780172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9510854A Ceased JPH11512108A (ja) | 1995-09-05 | 1996-09-03 | 鎮痛薬としての光学活性フェニルピリミジン誘導体 |
Country Status (32)
Country | Link |
---|---|
US (1) | US6124308A (ja) |
EP (1) | EP0879230B1 (ja) |
JP (1) | JPH11512108A (ja) |
KR (1) | KR19990044397A (ja) |
CN (1) | CN1200729A (ja) |
AP (1) | AP640A (ja) |
AR (1) | AR004192A1 (ja) |
AT (1) | ATE203523T1 (ja) |
AU (1) | AU710091B2 (ja) |
BG (1) | BG65102B1 (ja) |
BR (1) | BR9610388A (ja) |
CA (1) | CA2230362A1 (ja) |
CO (1) | CO4750651A1 (ja) |
CZ (1) | CZ65598A3 (ja) |
DE (1) | DE69614150T2 (ja) |
EA (1) | EA000695B1 (ja) |
ES (1) | ES2160834T3 (ja) |
GB (1) | GB9518027D0 (ja) |
HR (1) | HRP960399A2 (ja) |
HU (1) | HUP9901260A3 (ja) |
ID (1) | ID17274A (ja) |
IL (1) | IL123414A0 (ja) |
IS (1) | IS4673A (ja) |
NO (1) | NO980923L (ja) |
NZ (1) | NZ318390A (ja) |
PL (1) | PL325329A1 (ja) |
SK (1) | SK28598A3 (ja) |
TR (1) | TR199800386T1 (ja) |
TW (1) | TW367326B (ja) |
WO (1) | WO1997009317A2 (ja) |
YU (1) | YU49796A (ja) |
ZA (1) | ZA967466B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004504362A (ja) * | 2000-07-21 | 2004-02-12 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 神経障害性疼痛ならびに群発性頭痛および偏頭痛に関連する疼痛の予防もしくは治療における使用のためのカルバメート化合物 |
JP2010516734A (ja) * | 2007-01-24 | 2010-05-20 | グラクソ グループ リミテッド | 3,5−ジアミノ−6−(2,3−ジクロロフェニル)−1,2,4−トリアジンまたはr(−)−2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6−フルオロメチルピリミジンを含む医薬組成物 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR016212A1 (es) * | 1998-04-28 | 2001-06-20 | Astra Ab | Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas |
US6420354B1 (en) | 1998-06-08 | 2002-07-16 | Advanced Medicine, Inc. | Sodium channel drugs and uses |
AU4672699A (en) * | 1998-06-08 | 1999-12-30 | Theravance, Inc. | Novel sodium channel drugs and uses |
GB9907965D0 (en) * | 1999-04-09 | 1999-06-02 | Glaxo Group Ltd | Medical use |
US6479498B1 (en) | 1999-06-04 | 2002-11-12 | Theravance, Inc. | Sodium channel drugs and uses |
IL157608A0 (en) * | 2001-02-27 | 2004-03-28 | Teva Pharma | New crystal forms of lamotrigine and processes for their preparations |
IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
DE60312670T2 (de) * | 2002-04-23 | 2007-12-06 | Teva Pharmaceutical Industries Ltd. | Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie |
JP2006515326A (ja) * | 2003-01-30 | 2006-05-25 | ダイノジェン ファーマシューティカルズ, インコーポレイテッド | 胃腸管障害を処置するためのナトリウムチャネルモジュレーターの使用 |
GB0603087D0 (en) * | 2006-02-15 | 2006-03-29 | Glaxo Group Ltd | Novel use |
GB201111712D0 (en) | 2011-07-08 | 2011-08-24 | Gosforth Ct Holdings Pty Ltd | Pharmaceutical compositions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA803250B (en) * | 1979-06-01 | 1982-01-27 | Wellcome Found | Substituded aromatic compounds |
FI895821A0 (fi) * | 1988-12-07 | 1989-12-05 | Wellcome Found | Farmaceutiskt aktiva cns foereningar. |
-
1995
- 1995-09-05 GB GBGB9518027.9A patent/GB9518027D0/en active Pending
-
1996
- 1996-09-03 TR TR1998/00386T patent/TR199800386T1/xx unknown
- 1996-09-03 WO PCT/EP1996/003856 patent/WO1997009317A2/en not_active Application Discontinuation
- 1996-09-03 NZ NZ318390A patent/NZ318390A/xx unknown
- 1996-09-03 KR KR1019980701641A patent/KR19990044397A/ko not_active Application Discontinuation
- 1996-09-03 AU AU69865/96A patent/AU710091B2/en not_active Ceased
- 1996-09-03 CO CO96046885A patent/CO4750651A1/es unknown
- 1996-09-03 HU HU9901260A patent/HUP9901260A3/hu unknown
- 1996-09-03 PL PL96325329A patent/PL325329A1/xx unknown
- 1996-09-03 CZ CZ98655A patent/CZ65598A3/cs unknown
- 1996-09-03 ID IDP962513A patent/ID17274A/id unknown
- 1996-09-03 ES ES96931006T patent/ES2160834T3/es not_active Expired - Lifetime
- 1996-09-03 SK SK285-98A patent/SK28598A3/sk unknown
- 1996-09-03 EA EA199800189A patent/EA000695B1/ru not_active IP Right Cessation
- 1996-09-03 CA CA002230362A patent/CA2230362A1/en not_active Abandoned
- 1996-09-03 EP EP96931006A patent/EP0879230B1/en not_active Expired - Lifetime
- 1996-09-03 US US09/029,162 patent/US6124308A/en not_active Expired - Fee Related
- 1996-09-03 IL IL12341496A patent/IL123414A0/xx unknown
- 1996-09-03 DE DE69614150T patent/DE69614150T2/de not_active Expired - Lifetime
- 1996-09-03 CN CN96197823A patent/CN1200729A/zh active Pending
- 1996-09-03 AT AT96931006T patent/ATE203523T1/de not_active IP Right Cessation
- 1996-09-03 JP JP9510854A patent/JPH11512108A/ja not_active Ceased
- 1996-09-03 HR HR9518027.9A patent/HRP960399A2/hr not_active Application Discontinuation
- 1996-09-03 BR BR9610388A patent/BR9610388A/pt not_active Application Discontinuation
- 1996-09-04 AR ARP960104220A patent/AR004192A1/es unknown
- 1996-09-04 YU YU49796A patent/YU49796A/sh unknown
- 1996-09-04 ZA ZA9607466A patent/ZA967466B/xx unknown
- 1996-09-05 TW TW085110879A patent/TW367326B/zh active
- 1996-09-06 AP APAP/P/1996/000857A patent/AP640A/en active
-
1998
- 1998-02-23 IS IS4673A patent/IS4673A/is unknown
- 1998-03-04 NO NO980923A patent/NO980923L/no not_active Application Discontinuation
- 1998-03-23 BG BG102342A patent/BG65102B1/bg unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004504362A (ja) * | 2000-07-21 | 2004-02-12 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 神経障害性疼痛ならびに群発性頭痛および偏頭痛に関連する疼痛の予防もしくは治療における使用のためのカルバメート化合物 |
JP2010516734A (ja) * | 2007-01-24 | 2010-05-20 | グラクソ グループ リミテッド | 3,5−ジアミノ−6−(2,3−ジクロロフェニル)−1,2,4−トリアジンまたはr(−)−2,4−ジアミノ−5−(2,3−ジクロロフェニル)−6−フルオロメチルピリミジンを含む医薬組成物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7572785B2 (en) | Substituted imidazoles as cannabinoid receptor modulators | |
DE69326160T2 (de) | 4-carboxamidopiperidinderivate, zwischenprodukte und verwendung als neurokinin antagonisten | |
US20040248956A1 (en) | Substituted imidazoles as cannabinoid receptor modulators | |
CZ288944B6 (cs) | Derivát 5H-thiazolo[3,2-a]pyrimidinu, způsob jeho přípravy, meziprodukt pro jeho přípravu a farmaceutický prostředek, který ho obsahuje | |
HU221726B1 (hu) | Piperazinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására | |
JPH11512108A (ja) | 鎮痛薬としての光学活性フェニルピリミジン誘導体 | |
JP2000513383A (ja) | タキキニン受容体拮抗薬2−(r)−(1−(r)−(3,5−ビス(トリフルオロメチル)フェニル)エトキシ)−3−(s)−(4−フルオロ)フェニル−4−(3−(5−オキソ−1h,4h−1,2,4−トリアゾロ)メチルモルホリンの多形結晶 | |
JPH05320142A (ja) | 中枢神経系に薬理活性をもつ化合物 | |
JP2000505793A (ja) | 2,3―ベンゾジアゼピン誘導体及びそのampa―レセプター抑制剤としての使用 | |
JPH0367071B2 (ja) | ||
JP2000503308A (ja) | キノリン―2―(1h)―オン類 | |
HUT72740A (en) | Dimethylbenzofurans and dimethylbenzopyrans and they use for preparing pharmaceutical compositions having 5-ht3 antagonistic activity | |
EA008907B1 (ru) | Производные индола | |
HUT72677A (en) | Xanthine derivatives as adenosine a1 receptor antagonists | |
TWI258480B (en) | Novel piperidinecarboxamide derivatives, a method for their preparation and pharmaceutical compositions containing them | |
JP3353784B2 (ja) | 公知のブラジキニン拮抗剤のガラス体 | |
JP2010504316A (ja) | ムスカリン様受容体アンタゴニストとしてのアゼチジン誘導体 | |
JP2002532480A (ja) | モルホリノン及びモルホリン誘導体、ならびにその使用 | |
HU205920B (en) | Process for producing 2-phenoxy-methyl/-3-/alkanoyl-, carboxy-, carbalkoxy- or carboxamido- -acetyl/-1,3-thiazolidine derivatives and pharmaceutical compositions containing them | |
JP2002536442A (ja) | (1−フェナシル−3−フェニル−3−ピペリジルエチル)ピペリジン誘導体、その製造方法およびそれを含有する医薬組成物 | |
JP2003513095A (ja) | タキキニン受容体アンタゴニストの多形 | |
US6172078B1 (en) | Quinolinomorphinane derivatives and medicinal use thereof | |
JP2002541095A (ja) | アリールアルカノイルピリダジンの使用 | |
MXPA98001680A (en) | Derivative of phenyl pyrimidine optically active as analges agent | |
KR880001454B1 (ko) | 피리미도[4,5-g]퀴놀린 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050930 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20060320 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20060524 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060606 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060906 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061023 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061206 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070206 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070420 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070618 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070806 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071211 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080515 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080624 |